Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9

...

Orange Photonics: New High-Tech Testing For Psychedelic Products

October 20, 2023

Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business

October 20, 2023

Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues

October 20, 2023

New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma

October 19, 2023

EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations

October 18, 2023

Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M

October 17, 2023

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

October 16, 2023

U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy

October 15, 2023

Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy

October 13, 2023

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates

October 13, 2023

Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy

October 12, 2023

EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping

October 07, 2023

EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions

October 06, 2023

Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi

October 04, 2023

Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide

October 04, 2023

Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation

October 03, 2023

Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment

October 03, 2023

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

October 03, 2023

Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry

October 03, 2023

GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold

October 02, 2023

Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules

October 02, 2023

Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist

October 02, 2023

Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'

October 02, 2023

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

October 02, 2023

Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana

September 30, 2023

PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance

September 27, 2023

Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression

September 26, 2023

Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results

September 26, 2023

Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy

September 26, 2023

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More

September 26, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.